Published in Hepatitis Weekly, August 28th, 2006
Study 1: Post-transplant vaccination can be effective and offer liver transplant patients prophylaxis against de novo hepatitis B infection for a prolonged period of time.
According to recent research published in the journal Pediatric Transplantation, "Liver recipients who have antibodies to hepatitis B core antigen (anti-HBc) or received an anti-HBc positive liver graft are at risk of acquiring de novo hepatitis B infection so a life long prophylaxis is required. A post-transplant vaccination against hepatitis B virus (HBV) can...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2006-08-28)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.